This test is useful for quantitative (i.e., titer) evaluation of possible immunity in individuals who are at increased risk for exposure to hepatitis B (i.e., hemodialysis unit personnel, venipuncturists, etc.). This test can be used to evaluate the need for hepatitis B immune globulin after needlestick injury, to evaluate the need for hepatitis B vaccine and to follow immune status after hepatitis B vaccination.